Good MorningEquity markets advanced on Wednesday, but additional gains may not come this week. In prepared remarks for Congress, Fed Chief Jerome Powell let the market know that the committee was still a long way off from making the first policy change. In his view, inflation is tracking in the right direction, but there is still a risk of acceleration that will be amplified by cutting rates. Higher-for-longer is still in effect and may remain well into the 2nd half.
Employment data from ADP affirms the sentiment. ADP reports fewer new jobs than expected, but still a solid figure at 140,000. At this pace, investors should expect wage inflation to remain strong and underpin inflation generally throughout the economy. The NFP report is due tomorrow and will likely align with the idea that the FOMC doesn't need to cut rates yet. The caveat for bearish traders is that economic resilience will keep the FOMC from cutting rates, and economic resilience aligns with an uptrending S&P 500. Featured: This is the #1 Stock to Buy for the AI Tidal Wave (Chaikin Analytics) 
|
Markets | | |
Shares of Samsara (NYSE: IOT) have demonstrated remarkable resilience over the past year, showcasing an impressive 80% rise, outpacing the broader tech sector. While year-to-date performance shows a modest 5% increase, the stock's recent consolidation within a tight range sets the stage for a pote... Read the Full Story |
|
From Our PartnersAs you know, the stock market has been volatile lately, and there's a lot of uncertainty in the air. But we want to assure you that this is not the time to panic. In fact, it's the time to be buying stocks.
By clicking link you are subscribing to The Darwin Investor Network and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.
| | | | Download Our Free Report Here |
|
Markets | | |
The stock bull market seems to make new highs every week. You'll probably want to protect some of those profits if you rode the market recovery since the pandemic selloff. Selling your winners would result in a capital gains tax bill, not to mention potentially missing out on future gains. Instead... Read the Full Story |
|
Stocks | | |
With stock market chatter and headlines being dominated by only a handful of soaring tech stocks these days, it's refreshing to come across something new but equally promising. Paymentus Holdings, Inc. (NYSE: PAY) is a $2.5 billion fintech company based in North Carolina whose shares IPO... Read the Full Story |
|
From Our PartnersRarely do I label something as “the best’
But in this rare instance, I believe this is THE BEST indicator for trading Tesla’s stock.
Except, it’s not another tech stock…
But rather a stock hiding in broad daylight… | | | | Click this link here. |
|
Stocks | | | Embattled New York Community Bancorp announced a lifeline of more than $1 billion from a group of investors on Wednesday, after seeing its stock plunge by more than 80% this year. The announcement sent shares of the bank, which has been hammered by weakness in commercial real estate and growing pain... Read the Full Story |
|
Markets | | |
Okta Inc. (NASDAQ: OKTA) is a cybersecurity company that specializes in identity and access management (IAM) solutions. The computer and technology sector firm helps companies protect against identity-based attacks by providing services aimed at securing employee and customer identities. Some of i... Read the Full Story |
|
From Our PartnersThe #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas. | | | | Find Out What It Is Right Here |
|
Markets | | | China has plenty of room to maneuver to attain its annual target for robust economic growth of about 5% after a strong start for the year, top economic officials said Wednesday, though they acknowledged it's a challenge. China’s exports rose about 10% in the first two months of the year from a year ... Read the Full Story |
|
Markets | | |
The share price of Palantir Technologies Inc. (NYSE: PLTR) was sharply higher in pre-market trading on March 6, 2024. The company announced it has been awarded a two-year $178 million contract from the U.S. Army for its Tactical Intelligence Targeting Access Node (TITAN) program. These are mobile ... Read the Full Story |
|
Markets | | | Asian shares were mostly higher in early Thursday trading, after Wall Street recovered some losses from the day before. Japan's benchmark Nikkei 225 momentarily reached a record high in early trading but slipped later to 39,794.13, down 0.7%. Australia's S&P/ASX 200 rose nearly 0.1% to 7,740.80.... Read the Full Story |
|
Markets | | | Egypt on Wednesday floated its currency and announced a deal with the International Monetary Fund to increase its bailout loan from $3 billion to $8 billion, moving to shore up an economy hit by a staggering shortage of foreign currency and soaring inflation.The flotation of the Egyptian pound, comb... Read the Full Story |
|
Markets | | | Inflation in Europe is way down from its painful double-digit peak, and the economy has stalled. But the European Central Bank left its key interest rate at a record high Thursday, and its leader suggested a much-anticipated cut to borrowing costs would likely wait until June.The decision comes as c... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, Asia, and internationally. The company offers Regenacyn, a prescription scar gel; Pediacyn, a pediatric dermatology and wound care product for over-the-counter (OTC) use; Epicyn, an Antimicrobial Facial Cleanser; Levicyn, an HOCl based prescription and OTC product to use and relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis. It also provides Gramaderm for the treatment of topical mild to moderate acne; Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a wide range of pathogens; Ocucyn eyelid and eyelash cleanser; Microdacyn60 oral care solution for the treatment of mouth and throat infections; and Podiacyn, a foot care product. In addition, the company offers MicrocynAH, an HOCl-based solution designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin for healing; MicrocynVS, a veterinarian-strength animal care product used in vet clinics and animal hospitals; Nanocyn, a hospital-grade disinfectant; Acuicyn, an antimicrobial prescription solution for the treatment of blepharitis and the daily hygiene of eyelids and lashes; MucoClyns for the use in emergencies and safe to use on mucous membranes, cuts, abrasions, burns, and body surfaces; Endocyn root canal irrigation solutions; and Sinudox for nasal irrigation. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Boulder, Colorado. | | View Today's Stock Pick |
|
